And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

He said it makes things “more intense” when I’m squirming and trying not to go, and that the idea of me finally losing control—actually wetting myself, right as things heat up—really turns him on. At ...

Gene Holdings Inc. remains a Buy, driven by promising LEGEND trial data for detalimogene voraplasmid. Learn more about ENGN stock here.

BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ ...

Dubai: A civil court in Dubai has ordered construction, insurance, and equipment companies to pay Dh4 million in compensation to a young worker who was permanently paralysed after a workplace accident ...

Reported three-month complete response rate of 77.8% from the Phase 3 UTOPIA trial of UGN-103, consistent with ENVISION results; FDA agreed to ...

A new slow-release implant has shown unprecedented success in wiping out bladder cancer in more than 80 percent of patients, ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced its financial results for the fiscal ...

Does your dog suddenly show signs of pain, avoid movement, or walk unsteadily? Such symptoms can indicate dachshund paralysis ...

Allergan Aesthetics gives patients exciting BOTOX® Cosmetic offers only in the Allē app Buy one $50 gift card, get one free, ...

Multiple people across the globe who stepped forward are speaking about what they say is the debilitating aftermath they now ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $ (0.2) billion and GAAP EPS of $ (0.51) Improves 2025 ...